|
|
||||||||||
|
J Am Coll Cardiol, 2008; 51:920-929, doi:10.1016/j.jacc.2007.09.069 © 2008 by the American College of Cardiology Foundation |
,
,||,**,
,*
,








* Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy
Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
Molecular Cardiology Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
Clinical Pharmacokinetics Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
|| Laboratory of Cardiovascular Genetics, IRCCS Istituto Auxologico, Milan, Italy
¶ Department of Cardiology, Policlinico di Monza, Monza, Italy
# Centro Medico di Montescano, IRCCS Fondazione "Salvatore Maugeri," Montescano, Italy
** Department of Medicine, University of Stellenbosch, Stellenbosch, South Africa

Cardiovascular Genetics Laboratory, Hatter Institute for Cardiovascular Research, Department of Medicine, University of Cape Town, Cape Town, South Africa

US/MRC Centre for Molecular and Cellular Biology, University of Stellenbosch, Stellenbosch, South Africa

Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee.
Manuscript received June 6, 2007; revised manuscript received August 31, 2007, accepted September 20, 2007.
* Reprint requests and correspondence: Dr. Peter J. Schwartz, Professor and Chairman, Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Viale Golgi 19 - 27100 Pavia, Italy. (Email: pjqt{at}compuserve.com).
Objectives: The purpose of this study was to test the hypothesis that differences in autonomic responses might modify clinical severity in long QT syndrome type 1 (LQT1) patients, those with KCNQ1 mutations and reduced IKs, in whom the main arrhythmia trigger is sympathetic activation.
Background: Some long QT syndrome (LQTS) patients experience life-threatening cardiac arrhythmias, whereas others remain asymptomatic throughout life. This clinical heterogeneity is currently unexplained.
Methods: In a South African LQT1 founder population segregating KCNQ1-A341V, we correlated major cardiac events to resting heart rate (HR) and to baroreflex sensitivity (BRS) on and off beta-adrenergic blockers (BB).
Results: In 56 mutation carriers (MCs), mean HR was lower among asymptomatic patients (p < 0.05). Among MCs with a QT interval corrected for heart rate
500 ms, those in the lower HR tertile were less likely to have suffered prior cardiac events (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.04 to 0.79, p < 0.02). The BRS was lower among asymptomatic than symptomatic MCs (11.8 ± 3.5 ms/mm Hg vs. 20.1 ± 10.9 ms/mm Hg, p < 0.05). A BRS in the lower tertile was associated with a lower probability of being symptomatic (OR 0.13, 95% CI 0.02 to 0.96, p < 0.05). A similar trend was observed during BB. The MCs in the lower tertile for both HR and BRS were less frequently symptomatic than MCs with different patterns (20% vs. 76%, p < 0.05). Subjects with either ADRA2C-Del322-325 or homozygous for ADRB1-R389, 2 polymorphisms predicting enhanced adrenergic response, were more likely to have BRS values above the upper tertile (45% vs. 8%, p < 0.05).
Conclusions: Lower resting HR and "relatively low" BRS are protective factors in KCNQ1-A341V carriers. A plausible underlying mechanism is that blunted autonomic responses prevent rapid HR changes, arrhythmogenic when IKs is reduced. These findings help understanding phenotypic heterogeneity in LQTS and identify a physiological risk modifier, which is probably genetically determined.
| ||||||||||||
Related articles in JACC:
This article has been cited by other articles:
![]() |
R. Lazzara The congenital long QT syndrome: a mask for many faces. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 930 - 932. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |